Company news

Renalytix PLC news in 2025

Renalytix PLC's news releases, calls and decks from 2025, newest first.

View company

Result of AGM

December 9, 2025

Plan to Implement ADS Ratio Change

November 25, 2025

Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes

November 18, 2025

Pivotal kidneyintelX.dkd data published

November 12, 2025

Publication of Annual Report & Notice of AGM

November 4, 2025

Audited Full Year Fiscal 2025 Results

November 3, 2025

Confirmation of receipt of £860k R&D tax credits

October 27, 2025

$4m balance sheet improvement with bond conversion

October 10, 2025

CE Mark application submission

October 1, 2025

£7.05m total gross proceeds from Fundraise

September 26, 2025

Update Regarding Forward Guidance

September 24, 2025

Investor Presentation and Revised Revenue Guidance

September 23, 2025

Result of Fundraise

September 22, 2025

Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease

September 15, 2025

Services contract with Joslin and Pharma Partner

July 29, 2025

MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities

July 21, 2025

Partnership with MVP Health Care

July 17, 2025

kidneyintelX.dkd data presented at ERA Congress

June 17, 2025

Growing collaboration with NYKHM

June 3, 2025

First use of KidneyIntelX in new CKD therapy trial

May 20, 2025

Late Breaking KidneyIntelX data show care impact

April 16, 2025

Q3 Trading Update

April 10, 2025

Notice of Interim Results & Investor Presentation

March 12, 2025

Publication in journal (JASN) for kidneyIntelX.dkd

February 6, 2025

Trading Update

January 27, 2025

Foreign Private Issuer re-qualification

January 17, 2025

Calls in 2025

Decks in 2025